This article provides a comprehensive comparative analysis of the distinct molecular signatures that define Cancer Stem Cells (CSCs) and normal stem cells.
This article provides a comprehensive analysis of the rapidly evolving landscape of emerging biomarkers for early cancer detection, tailored for researchers, scientists, and drug development professionals.
This article provides researchers, scientists, and drug development professionals with a comprehensive framework for single-cell RNA sequencing (scRNA-seq) validation within the tumor microenvironment (TME).
This article provides a comprehensive comparison of mouse models and the human tumor microenvironment (TME) for researchers and drug development professionals.
This article provides a comprehensive framework for researchers, scientists, and drug development professionals on the validation of immunohistochemistry (IHC) within tumor microenvironment (TME) models.
This article provides a comprehensive framework for leveraging advanced histopathology to validate emergent biological behaviors in disease models and drug development.
This article provides a comprehensive comparison between traditional 2D and emerging 3D tumor models for researchers and drug development professionals.
This article provides a comprehensive framework for researchers and drug development professionals to benchmark Tumor Microenvironment (TME) scoring algorithms.
The classification of the Tumor Microenvironment (TME) into distinct subtypes is emerging as a critical determinant of cancer prognosis and response to therapy, particularly immunotherapy.
This article provides a comprehensive analysis of emergent behaviors—complex system-level properties arising from component interactions—across in vitro and in vivo environments.